期刊文献+

羟基氯喹对系统性红斑狼疮患者血脂的影响

下载PDF
导出
摘要 目的观察羟基氯喹对系统性红斑狼疮患者血脂的影响及不良反应。方法对110例系统性红斑狼疮患者分为观察组和治疗组,观察治疗前后两组患者血脂的水平并进行统计学分析。结果两组患者实验前血脂水平比较无明显差异(P>0.05)。对照组治疗前后观察项目差异无显著性(P>0.05)。观察组治疗前后观察项目差异有显著性(P<0.05)。HCQ组与对照组在12个月观察结束时,所有观察血脂项目差异均有显著性(P<0.05)。结论HCQ具有明确的改善SLE患者血脂的作用。对于没有应用HCQ禁忌症的轻、中度SLE患者尽量早期应用HCQ治疗。
出处 《宁夏医学杂志》 CAS 2007年第7期624-625,共2页 Ningxia Medical Journal
  • 相关文献

参考文献7

  • 1Weiss mann G.Lysosomes[J].N Engl J Med,1965,273:1141.
  • 2Van den Borne BE,Di jkmans BA,de Rooij,et al.Chloroquine and hydroxychloroquine equally affect tumor necrosis factoralpha,interleukin 6,and interfreron-gamma production by peripheral blood mononuclear cells[J].J Rheumatal,1997,24(1):55-60.
  • 3Goldman FD,Gilman AL,Hollenback C,et al.Hydroxychloroquine inhibitis calcium signals in T cells:a new mechanism to explain its immunomodulatory properties[J].Blood,2000,11:3460-3466.
  • 4Wallace J,Metzger AL,Stecher VJ,et al.Cholesterol lowering effect of hydroxychloroquine(plaquenil) in rheumatoid disease patients.Reversal of deleterious effects of steroids on lipids[J].Am J Med,1990,89(3):322-366.
  • 5Hodis H N,Quismorio F P Jr,Wickham E,et al.The lipid,lipoprotein and apolipoprotein effects of hydroxychloroquine in patients with SLE[J].J Rheumatol,1993,20(4):661-665.
  • 6汪志红,张素华,倪银星,吴静,王继旺,龚俐琳.羟氯喹增加胰岛素抵抗大鼠模型胰岛素敏感性的实验研究[J].重庆医科大学学报,2004,29(4):429-432. 被引量:7
  • 7Emani J,Pasutto FM,Mercer JR,et al.Inhibition of insulin of metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from herlthy and diabetic rats[J].Life Sci,1999,64(5):325-335.

二级参考文献11

  • 1Quatraro A,Consoli G,Magno M,et al. Hydroxychloroquine in Decompensated, Treatment - Refractory NoninsulinDependent Diabetes Mellitus[J]. Ann Intern Med, 1990; 112(9) :678 - 681.
  • 2Storlien LH,Oakes ND, Pan D, et al. Syndromes of insulin resistance in the rat. Inducement by diet and the amelioration with benfluorex[J]. Diabetes, 1993 ;42:457 - 460.
  • 3J eppsen J ,Zhou MY, Chen YD, et al. Effect of metformin on postprandial lipidemia in patients with fairly to peorly controlled NIDDM[J]. Diabetes care. 1994; 17(10): 1093 - 1099.
  • 4Pederson O, Kahn CR, Flier JS, et al. High fat feeding cause insulin resistance and a marked decrease in the expression of glucose transporters ( Glut - 4) in fat cells of rats [J]. Endocrinology, 1991; 129: 771 - 777.
  • 5Emani J, Pasutto FM, Mercer JR, et al. Inhibition of insulin of metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats[J]. Life Sci, 1999;64(5) :325 - 35.
  • 6Bailey CJ,Turner RC. Metformin[J]. N Enl J Med.1996;334(9) :574 - 579.
  • 7Saltiel AR, Olefsky J. Thiazolidinediones in the treatment of insulin resistance and type 2 diabetes[J]. Diabetes.1996;45(12): 1661 - 1669.
  • 8Petri M. Hydroxychloroquine used in the Baltimore Lupus Cohort: effects on lipids glucose and thrombosis [J]. Lupus,1996;5(1) :S16 - 22.
  • 9Powrie JK, Smith GD, Shojaee - Moradie F, et al. Mode of action of chloroquine in patients with non - insulin - dependent diabetes mellitus [J]. Am J Physiol, 1991; 260 ( 6 Pt 1 ):E897 - 904.
  • 10Shojania K, Koehler BE, Elliott T. Hypoglycemia induced by hydroxychloroquine in a type Ⅱ diabetic treated for polyarthritis[J]. J Rheumatol, 1999;26(1): 195 - 196.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部